Abstract
Mycobacterial growth.
Mycobacterium tuberculosis strain H37Ra was grown in 7H9 liquid medium (Difco) supplemented with 0.05 % Tween 80 and 10 % bovine serum albumin-dextrose-catalase (ADC) enrichment (Difco) at 37 °C for approximately 7 days (mid- to late-exponential phase) with occasional agitation.
PZA, isoniazid (INH), rifampicin (RIF), 1,3-dicyclohexylcarbodiimide (DCCD), sodium azide, rotenone and sodium nitrate were obtained from Sigma-Aldrich. PZA, INH, sodium azide and sodium nitrate were dissolved in deionized water at stock concentrations of 10 mg ml1, 50 µg ml1, 20 mM and 1 M, respectively, and filter-sterilized. RIF was dissolved in DMSO at a stock concentration of 10 mg ml1. DCCD and rotenone were dissolved in 95 % ethanol at stock concentrations of 200 mM and 800 µM, respectively. All drugs were freshly prepared each day before use.
Mycobacterial growth.
Mycobacterium tuberculosis strain H37Ra was grown in 7H9 liquid medium (Difco) supplemented with 0.05 % Tween 80 and 10 % bovine serum albumin-dextrose-catalase (ADC) enrichment (Difco) at 37 °C for approximately 7 days (mid- to late-exponential phase) with occasional agitation.
Effect of aeration on PZA activity.
Cells from a 7-day-old M. tuberculosis H37Ra culture were harvested by centrifugation at 2800 g for 10 min at 4 °C, washed in PBS (pH 7.0) and then resuspended in 7H9 medium, adjusted to pH 5.5 using HCl, to a cell density of about 106107 bacilli ml1 based on a standard curve. The cell suspension was then divided into 5 or 15 ml aliquots that received 100 µg PZA ml1, along with controls that received no PZA, followed by incubation at 37 °C for 5 days under aerobic, microaerobic and anaerobic conditions. For aerobic conditions 5 ml aliquots were placed in 50 ml tubes and incubated with rotary aeration at 220 r.p.m., while for microaerobic conditions 15 ml aliquots were placed in 15 ml standing tubes with limited headspace (less than 2 ml). A BBL GasPak 100 anaerobic system (Becton Dickinson) was used for anaerobic conditions, where 5 ml aliquots in 15 ml tubes were incubated in a 2.5-litre jar with a BBL GasPak Plus anaerobic system envelope with palladium catalyst. Methylene blue indicator strips were used to verify anaerobic conditions, where the indicator strip remained colourless during the experiment. After 5 days of incubation, the cells from 5 ml aliquots were harvested by centrifugation as described above, washed with PBS (pH 7.0), serially diluted and plated in triplicate on 7H11 agar plates supplemented with ADC. Plates were incubated at 37 °C for 34 weeks prior to determining the number of c.f.u. ml1.
Effect of aeration on synergy between ATPase and respiratory chain enzyme inhibitors and PZA.
Cells from a 7-day-old M. tuberculosis H37Ra culture were harvested as described above, washed in one volume of PBS (pH 7.0) and resuspended in citrate buffer (pH 5.0 or 7.0). The cells were treated with rotenone (4 µM), 1,3-DCCD (1 mM), sodium azide (0.1 mM) or PZA (100 µg ml1), or rotenone, DCCD or sodium azide in combination with PZA, followed by incubation for 5 days at 37 °C under aerobic or anaerobic conditions as described above. After 5 days the cells were washed with PBS (pH 7.0) and the number of c.f.u. ml1 for each sample was determined as described above. Cells were also treated with INH (0.5 µg ml1) or RIF (4 µg ml1) alone or in combination with rotenone, DCCD or sodium azide in order to determine if synergy with inhibitors was specific to PZA.
Effect of sodium nitrate on PZA activity under anaerobic conditions.
Cells from a 7-day-old M. tuberculosis H37Ra culture were harvested by centrifugation as described above, washed in one volume of PBS (pH 7.0) and resuspended in citrate buffer (pH 5.0 or 7.0). The cells were treated with sodium nitrate (10 mM) or PZA (100 µg ml1), or sodium nitrate in combination with PZA, followed by incubation for 5 days at 37 °C under anaerobic conditions in GasPak jars as described above. After 5 days the cells were washed with PBS (pH 7.0) and the number of c.f.u. ml1 was determined.
|
We used a sudden shift of the oxygen conditions in this study. This was because we wanted to test the effect of oxygen concentration on PZA activity in a more controllable fashion. We started with the same inoculum culture and the same number of cells for aerobic, microaerobic and anaerobic conditions for the purpose of easy comparison, whereas if the Wayne model of dormancy (Wayne & Hayes, 1996) had been used, we would not have been able to easily compare the effect of oxygen on PZA activity. While we expect the finding of enhancement of PZA activity by sudden exposure to low oxygen in this study to be applicable to the slow adaptation to microaerobic or anaerobic conditions in the Wayne model, this remains to be confirmed in future studies.
Previously, our laboratory has reported an enhancement of PZA activity by various inhibitors of the electron transport chain (Zhang et al., 2003). This synergy of PZA with various inhibitors is likely to be due to the decrease in energy production caused by the inhibitors, which is exacerbated by PZA, based on the above model of PZA mode of action. In the present study, the effect of anaerobiosis on that synergy was examined. DCCD, an ATPase inhibitor, rotenone, a Complex 1 inhibitor and sodium azide, a cytochrome c oxidase inhibitor, were included because of a prior observation of their enhancement of PZA activity. Fig. 2 shows the results of treating M. tuberculosis with PZA or various ATPase or respiratory chain enzyme inhibitors or a combination thereof under aerobic and anaerobic conditions at pH 5.0 and 7.0. Under aerobic conditions at pH 5.0 an enhanced effect of PZA activity was observed when PZA was administered in combination with either DCCD, azide or rotenone (Fig. 2a) as reported previously (Zhang et al., 2003). A greater than 10-fold reduction in c.f.u. ml1 was observed for PZA plus DCCD, azide or rotenone compared with PZA alone. At pH 7.0 no enhancement of PZA activity by enzyme inhibitors was observed (Fig. 2b, d), as was expected, considering PZA is only active at acidic pH (McDermott & Tompsett, 1954). The presence of enzyme inhibitors did not result in additional enhancement of PZA activity under anaerobic conditions (Fig. 2c). This is probably because under anaerobic conditions there is no significant electron transport activity in tubercle bacilli such that the electron transport inhibitors have no effect and therefore cannot provide additional enhancement of PZA activity (Fig. 1).
|
We also examined the effect of proton motive force inhibitors administered in conjunction with the alternative drugs INH and RIF to determine whether the enhancement effect caused by the inhibitors was specific to PZA. We detected no enhanced effect of INH or RIF when given in combination with DCCD, azide or rotenone under either aerobic or anaerobic conditions at pH 5.0 or 7.0 (Fig. 3). Therefore, we conclude that the increased sterilizing activity observed for PZA when combined with energy inhibitors is specific to PZA.
|
Lastly, we tested the effect of alternative electron acceptors on PZA activity under anaerobic conditions. Although M. tuberculosis is generally thought to be an obligate aerobe, the presence of genes encoding enzymes required for anaerobic metabolism, such as nitrate reductases (Cole et al., 1998), and the slow adaptation of M. tuberculosis to microaerobic and anaerobic conditions as shown in the Wayne model (Wayne & Hayes, 1996) suggest that M. tuberculosis can at least survive under such conditions for some time. Based on our current model of PZA mode of action (Zhang et al., 1999, 2003; Zhang & Telenti, 2000), we hypothesized that if tubercle bacilli were given nitrate as an alternative electron acceptor under anaerobic conditions, allowing for energy production to compensate for the depletion of energy caused by PZA, the activity of PZA might be reduced. Indeed antagonism of PZA activity was observed when cells were treated with PZA in the presence of nitrate (Fig. 4) such that the c.f.u. ml1 of samples treated with PZA plus nitrate was the same as the untreated control, whereas PZA-treated bacilli under anaerobic conditions in the absence of nitrate had a lower c.f.u. ml1 as expected (Fig. 4).
|
It is worth noting that the susceptibility of tubercle bacilli to PZA has never been tested under anaerobic or hypoxic conditions, since M. tuberculosis is a strict aerobe and would not grow in the absence of oxygen in drug susceptibility test settings. The current PZA susceptibility testing was performed in the presence of atmospheric oxygen (approx. 20 %) where tubercle bacilli grow well. PZA is a peculiar and unconventional drug that does not kill growing cultures very well, but kills old, non-growing cultures with less energy reserves more effectively (Zhang et al., 2002). In this study we have shown that anaerobic or hypoxic conditions, which do not allow tubercle bacilli to grow, enhanced the activity of PZA (Fig. 1). In addition to acid pH (McDermott & Tompsett, 1954) and iron (Somoskovi et al., 2004) that enhance the activity of PZA, this study provides another explanation for the high sterilizing activity of PZA against tubercle bacilli in vivo in granulomatous lesions with low oxygen. Additionally, we have shown that PZA activity is decreased when tubercle bacilli are supplied with the alternative electron acceptor nitrate for energy production under anaerobic conditions. These observations provide further support for our model of the mode of action of PZA, whereby PZA disrupts the membrane potential and energy store of old, non-growing tubercle bacilli with little metabolic activity or energy reserves, which leads to a slow death of the bacilli (Zhang et al., 2003).
The work was supported by research funding from NIH (AI44063 and AI49485). M. M. W. was supported by NIH training grant T32 AI07608.References
- Canetti, G. (1955). The Tubercle Bacillus in the Pulmonary Lesion of Man. New York: Springer.
- Cole, S. T., Brosch, R., Parkhill, J. & 39 other authors. (1998). Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537544.[CrossRef][Medline]
- Heifets, L. & Lindholm-Levy, P. (1992). Pyrazinamide sterilizing activity in vitro against semidormant Mycobacterium tuberculosis bacterial populations. Am Rev Respir Dis 145, 12231225.[Medline]
- McDermott, W. & Tompsett, R. (1954). Activation of pyrazinamide and nicotinamide in acidic environments in vitro. Am Rev Tuberc 70, 748754.[Medline]
- Mitchison, D. (1985). The action of antituberculosis drugs in short-course chemotherapy. Tubercle 66, 219225.[CrossRef][Medline]
- Somoskovi, A., Wade, M. M., Sun, Z. & Zhang, Y. (2004). Iron enhances the antituberculous activity of pyrazinamide. J Antimicrob Chemother 53, 192196.
[Abstract/Free Full Text]
- Tarshis, M. S. & Weed, W. A., Jr (1953). Lack of significant in vitro sensitivity of Mycobacterium tuberculosis to pyrazinamide on three different solid media. Am Rev Tuberc 67, 391395.
- Wayne, L. G. & Hayes, L. G. (1996). An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun 64, 20622069.[Abstract]
- Zhang, Y. & Telenti, A. (2000). Genetics of drug resistance in Mycobacterium tuberculosis. In Molecular Genetics of Mycobacteria, pp. 235254, Edited by G. Hatfull & W. R. Jacobs Jr. Washington, DC: ASM Press.
- Zhang, Y. & Mitchison, D. A. (2003). The curious characteristics of pyrazinamide: a review. Int J Tuberc Lung Dis 7, 621.[Medline]
- Zhang, Y., Scorpio, A., Nikaido, H. & Sun, Z. H. (1999). Role of acid pH and deficient efflux of pyrazinoic acid in the unique susceptibility of Mycobacterium tuberculosis to pyrazinamide. J Bacteriol 181, 20442049.
[Abstract/Free Full Text]
- Zhang, Y., Permar, S. & Sun, Z. (2002). Conditions that may affect the results of Mycobacterium tuberculosis susceptibility testing to pyrazinamide. J Med Microbiol 51, 4249.
[Abstract/Free Full Text]
- Zhang, Y., Wade, M. M., Scorpio, A., Zhang, H. & Sun, Z. (2003). Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. J Antimicrob Chemother 52, 790795.
[Abstract/Free Full Text]